Study of Malaria Vaccine Candidates in India
Author Information
Author(s): Prajapati Surendra K, Joshi Hema, Dua Virendra K
Primary Institution: National Institute of Malaria Research (NIMR)
Hypothesis
This study aims to identify genetic variations in transmission-blocking vaccine candidates Pvs25 and Pvs28 from Plasmodium vivax in the Indian subcontinent.
Conclusion
The study uncovered many new amino acid substitutions and a predominance of a single haplotype in the Indian subcontinent, which could aid in designing a more effective anti-malarial transmission-blocking vaccine.
Supporting Evidence
- The study identified 26 amino acid substitutions in Pvs25 and Pvs28.
- A single major haplotype was observed among isolates from Delhi, Nadiad, Chennai, and Panna.
- The majority of amino acid substitutions in Indian isolates were similar to those reported from Thailand and Bangladesh.
Takeaway
Researchers looked at the genes of malaria parasites from India to find differences that could help make better vaccines.
Methodology
Blood samples from 100 P. vivax isolates were collected from five regions in India, and the genes Pvs25 and Pvs28 were PCR amplified and sequenced.
Potential Biases
Potential bias in sample collection as isolates were only taken from symptomatic patients.
Limitations
The study may not represent all geographical variations within the Indian subcontinent due to the limited number of isolates from certain regions.
Participant Demographics
Isolates were collected from five geographical regions in India: Delhi, Chennai, Kamrup, Nadiad, and Panna.
Statistical Information
P-Value
p<0.001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website